tiprankstipranks
Trending News
More News >
Glenmark Life Sciences Limited (IN:GLS)
:GLS
India Market

Glenmark Life Sciences Limited (GLS) Financial Statements

Compare
1 Followers

Glenmark Life Sciences Limited Financial Overview

Glenmark Life Sciences Limited's market cap is currently ₹128.15B. The company's EPS TTM is ₹11.35; its P/E ratio is 26.37; and it has a dividend yield of 3.96%. Glenmark Life Sciences Limited is scheduled to report earnings on May 15, 2025, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Mar 23Mar 22Mar 21Mar 20
Income Statement
Total Revenue₹ 22.83B₹ 21.61B₹ 21.23B₹ 18.85B₹ 15.37B
Gross Profit₹ 12.43B₹ 11.47B₹ 10.80B₹ 9.80B₹ 8.47B
Operating Income₹ 8.98B₹ 6.01B₹ 5.79B₹ 5.62B₹ 4.44B
EBITDA₹ 6.86B₹ 6.71B₹ 6.31B₹ 5.92B₹ 4.84B
Net Income₹ 4.71B₹ 4.67B₹ 4.19B₹ 3.52B₹ 3.13B
Balance Sheet
Cash & Short-Term Investments₹ 3.01B₹ 3.80B₹ 5.17B₹ 1.40B₹ 307.68M
Total Assets₹ 28.50B₹ 27.02B₹ 24.71B₹ 19.97B₹ 17.26B
Total Debt₹ 171.48M₹ 193.57M₹ 28.84M₹ 9.33B₹ 210.00K
Net Debt₹ -2.84B₹ -2.64B₹ -5.09B₹ 8.17B₹ -99.77M
Total Liabilities₹ 5.18B₹ 5.64B₹ 4.17B₹ 12.44B₹ 13.24B
Stockholders' Equity₹ 23.32B₹ 21.38B₹ 20.54B₹ 7.53B₹ 4.02B
Cash Flow
Free Cash Flow₹ 2.85B₹ 1.43B₹ 4.65B₹ 3.20B₹ 1.44B
Operating Cash Flow₹ 4.14B₹ 3.13B₹ 5.98B₹ 3.88B₹ 1.95B
Investing Cash Flow₹ -1.16B₹ -1.54B₹ -1.22B₹ -687.34M₹ -505.18M
Financing Cash Flow₹ -2.79B₹ -3.88B₹ -787.96M₹ -2.14B₹ -1.37B
Currency in INR

Glenmark Life Sciences Limited Earnings and Revenue History

Glenmark Life Sciences Limited Debt to Assets

Glenmark Life Sciences Limited Cash Flow

Glenmark Life Sciences Limited Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis